Gefshil 250mg Tablet: Effective Relief for You

Gefshil 250mg Tablet

Uses:

• Treatment of non-small cell lung cancer (NSCLC) in patients where the cancer has spread, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Therapeutic Effects:

• Gefshil 250mg Tablet is an anilinoquinazoline derivative that interacts with a kinase inhibitor, inhibiting an abnormal protein called the epidermal growth factor receptor (EGFR). This helps to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.

Dosage and Administration:

• The medicine is prescribed by a healthcare professional.
• Available as a tablet to be taken with or without food, as directed by your healthcare provider.
• Usual recommended dosage is 250 mg tablet once daily.
• Swallow the tablet whole with a glass of water.
• Take the Gefshil 250mg tablet at the same time every day.

Safety Advice:

• Pregnancy: Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
• Breastfeeding: It is unsafe to breastfeed during the treatment with this Gefshil 250mg Tablet. Consult your doctor before breastfeeding.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Inform your physician if you have any liver problems before starting treatment.
• Alcohol: Avoid consuming alcohol as it may cause dizziness.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking the Gefshil 250mg Tablet.

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.

Storage:

• Store Gefshil 250mg Tablet in the original package at room temperature (25°C).
• Keep it out of reach from children.

Missed Dose:

• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Side Effects:

• Common side effects include diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, blood in the urine, and burning sensation while urinating.

Word of Advice:

• Gefshil 250mg is not recommended for children and adolescents below 18.
• Monitor your blood pressure regularly during this treatment.
• Avoid high-fiber foods and drink lots of fluids if you have severe diarrhea.
• Antacids should not be used two hours before or one hour after taking this tablet.
• Avoid driving and operating heavy machinery if you feel tired or weak during this treatment.

FAQ:

1. What are the Gefshil 250mg tablet side effects?

   • Diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, nosebleed, blood in the urine, and burning sensation while urinating are the common Gefshil 250mg side effects.

2. Is Gefshil 250mg targeted therapy?

   • Yes, Gefshil 250mg Tablet is a targeted drug therapy that helps to treat advanced non-small-cell lung cancer (NSCLC).

3. Who should not use Gefshil 250mg tablets?

   • Gefshil 250mg is not indicated for children and adolescents under the age of 18. It should not be used in people who are allergic to this drug, as well as pregnant or breastfeeding women.

4. Is it safe for women of reproductive potential to use Gefshil 250mg tablets?

   • Gefshil 250mg tablets are not recommended for use during pregnancy and breastfeeding. Tell your healthcare provider before starting this treatment if you are pregnant, think you might be pregnant, breastfeeding, or planning to have a baby.

5. What should I avoid while taking Gefshil 250mg tablets?

   • It is advised to avoid taking an antacid or stomach acid-reducing medication within two hours before or one hour after taking a Gefshil 250mg tablet.

Fact Box:

• Molecule name: Gefitinib
• Therapeutic class: Antineoplastics
• Pharmacological class: Tyrosine kinase inhibitors
• Indications: Non-small cell lung cancer

Tags: medication, tablets, gefshil, 250mg, health, pharmacy, drug, treatment